- Home
- / Plus Therapeutics
Plus Therapeutics
Stock Price
$1.4
2024-10-29
Market Capitalization
$8 M
2024-10-29
Revenue
$5.2 M
FY, 2025
Plus Therapeutics Summary
Company Summary
- Overview
- Plus Therapeutics (formerly known as Cytori Therapeutics) is a pharmaceutical company focused on the discovery, development, and manufacturing of treatments for patients battling cancer and other life-threatening diseases. The company delivers a range of drugs using liposomal encapsulation technology.
- Type
- Public
- Status
- Active
- Founded
- 1996
- HQ
- Austin, TX, US | view all locations
- Cybersecurity rating
Table of Contents
Key People
Andrew Sims, Vice President and Chief Financial Officer
Cheri Rice, Vice President, Product Development
Norman Lafrance, Chief Medical Officer and Senior Vice President
LocationsView all
2 locations detected
Austin, TX HQ
United States
4200 Marathon Blvd #200
San Antonio, TX
United States
12500 Network Blvd
Plus Therapeutics Financials
Summary Financials
- Revenue (FY, 2025)
- $5.2M
- Net income (FY, 2025)
- ($22.4M)
- Cash (FY, 2025)
- $4.3M
- EBIT (FY, 2025)
- ($15.3M)
- Enterprise value
- $4.5M